Clinical trials
Phase 1 trials in Finland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
155 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2005 | 2 |
| 2006 | 5 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 14 |
| 2010 | 7 |
| 2011 | 9 |
| 2012 | 6 |
| 2013 | 7 |
| 2014 | 9 |
| 2015 | 8 |
| 2016 | 6 |
| 2017 | 7 |
| 2018 | 13 |
| 2019 | 6 |
| 2020 | 9 |
| 2021 | 8 |
| 2022 | 3 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 109 |
| Terminated | 18 |
| Unknown status | 10 |
| Recruiting | 8 |
| Active, not recruiting | 8 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Orion Corporation, Orion Pharma | 35 |
| Bayer | 11 |
| H. Lundbeck A/S | 6 |
| Turku University Hospital | 6 |
| Helsinki University Central Hospital | 5 |
| Novartis Pharmaceuticals | 5 |
| University of Turku | 5 |
| GlaxoSmithKline | 4 |
| Hoffmann-La Roche | 4 |
| Herantis Pharma Plc. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asthma | 10 |
| Neoplasms | 10 |
| Alzheimer Disease | 8 |
| Parkinson Disease | 6 |
| Leukemia, Myeloid, Acute | 4 |
| Central Nervous System Diseases | 3 |
| Lymphoma | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Melanoma | 3 |
| Myelodysplastic Syndromes | 3 |
Trials
Showing 1 to 25 of 155. Each trial links to its page on Pharma Observatory.
55 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.